|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$18,897
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-18
|
$1,680,173
|
$1,680,173
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vitamin D Status and Prostate Cancer
|
5R01CA101113-05
|
$315,551
|
$315,551
|
FLEET, JAMES
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Vitamin D and Soy Isoflavone Inhibition of Prostate
|
5R01CA101023-05
|
$251,038
|
$251,038
|
CRAMER, SCOTT
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-04
|
$244,382
|
$122,191
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Vitamin D and Colorectal Cancer
|
1R01CA122299-01A2
|
$360,095
|
$360,095
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$36,260
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
1R01CA131133-01A1
|
$274,730
|
$274,730
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
VHL
|
Z01 CP005803-08290
|
$4,523
|
$452
|
Goldstein, Alisa
|
DCEG (NCI)
|
|
VCU Minority-Based CCOP
|
5U10CA052784-18
|
$577,110
|
$46,169
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$3,597
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$287,729
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$123,114
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
1R01CA125691-01A2
|
$354,513
|
$354,513
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
$367,507
|
Keefer, Larry
|
CCR (NCI)
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-33S1
|
$74,165
|
$2,967
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-33
|
$6,658,653
|
$266,346
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Uptake of Vitamin A and Breast Cancer
|
5R03CA128091-03
|
$71,500
|
$71,500
|
ROWLING, MATTHEW
|
IOWA STATE UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$150,438
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
2U54CA096300-06A1
|
$1,216,467
|
$231,129
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
|
5P01CA017054-30
|
$2,034,926
|
$508,732
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$3,239
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-24
|
$1,553,887
|
$62,155
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-04S1
|
$60,563
|
$3,028
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-04
|
$1,332,378
|
$66,619
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$611
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$59,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$73,181
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S4
|
$2,630,152
|
$78,905
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S5
|
$61,584
|
$1,848
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Ultraviolet-Induced Signal Trasduction
|
5R01CA077646-09
|
$236,453
|
$59,113
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Ulcerative colitis-associated cancer and its prevention
|
5R01CA104741-06
|
$216,840
|
$216,840
|
YANG, GUANG-YU
|
NORTHWESTERN UNIVERSITY
|
|
UCLA SPORE in Prostate Cancer
|
5P50CA092131-07
|
$2,346,813
|
$469,363
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UAB Cancer Research Experiences for Students (CaRES)
|
5R25CA076023-10
|
$332,353
|
$33,235
|
WATERBOR, JOHN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor suppression by sphingolipids: role of beta-catenin
|
5R01CA109019-04
|
$262,767
|
$262,767
|
SCHMELZ, EVA
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
Translational Research of Finasteride and Selenium Prevention of Prostate Cancer
|
5P01CA126804-02
|
$1,040,238
|
$1,040,238
|
IP, CLEMENT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Translational Research in Cancer
|
2P30CA056036-09
|
$3,116,058
|
$31,161
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-09S1
|
$63,390
|
$634
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Breast Cancer
|
2P50CA058183-14
|
$2,300,000
|
$276,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Transgenic Models for Prostate and Breast Cancer
|
Z01 BC 005740
|
$1,453,669
|
$145,367
|
Green, Jeffrey
|
CCR (NCI)
|
|
Transcriptional & cell cycle control by dietary indoles
|
5R01CA102360-05
|
$257,229
|
$128,615
|
FIRESTONE, GARY
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-25
|
$721,858
|
$57,749
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Tocopherylquinone as a novel chemopreventive agent for prostate cancer
|
1R03CA133941-01
|
$75,000
|
$75,000
|
Thompson, Todd
|
UNIVERSITY OF NEW MEXICO
|
|
Timing of dietary exposure and breast cancer risk
|
3U54CA100970-05S1
|
|
$0
|
HILAKIVI-CLARKE, LEENA
|
GEORGETOWN UNIVERSITY
|
|
Therapeutic immunosuppression, inflammation & skin cancer
|
5R01CA109204-04
|
$251,966
|
$75,590
|
OBERYSZYN, TATIANA
|
OHIO STATE UNIVERSITY
|
|
The role of selenoproteins in the etiology of cancer
|
5R01CA115616-04
|
$223,970
|
$22,397
|
MOOS, PHILIP
|
UNIVERSITY OF UTAH
|
|
The Role of Selenium in Intestinal Inflammation and Cancer
|
5R21CA123334-02
|
$199,200
|
$199,200
|
Jelicks, Linda
|
YESHIVA UNIVERSITY
|
|
The Role of Regulation of FOXO3a in Tumor Suppression
|
5R01CA113859-03
|
$234,227
|
$234,227
|
HU, MICKEY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
|
Z01 BC 010026
|
$490,395
|
$147,119
|
Colburn, Nancy
|
CCR (NCI)
|
|
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
|
5R01CA122042-02
|
$292,600
|
$292,600
|
Eibl, Guido
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Chemoprevention for this search: $168,074,275
|